High Mark Wealth Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

High Mark Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$58.38 - $84.96 $11,734 - $17,076	-201 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$62.15 - $90.32 $124 - $180	2 Added 1.01%	201 $17,000
Q1 2021 Apr 22, 2021	SELL	$61.35 - $90.47 $13,374 - $19,722	-218 Reduced 52.28%	199 $13,000
Q4 2020 Jan 27, 2021	SELL	$43.82 - $85.37 $28,789 - $56,088	-657 Reduced 61.17%	417 $32,000
Q3 2020 Oct 26, 2020	BUY	$33.21 - $51.27 $35,667 - $55,063	1,074 New	1,074 $46,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.